Endothelium-Derived Nitric Oxide Contributes to the Vasorelaxant Response Induced by Mesoionic 2-(4-Chlorophenyl)-3-methyl-4-(4-methoxyphenyl)-3;3-thiazolium-5-thyolate (CMMTT) in Rats
スポンサーリンク
概要
- 論文の詳細を見る
This study was performed to investigate the mechanisms involved in the vasorelaxation induced by mesoionic 2-(4-chlorophenyl)-3-methyl-4-(4-methoxyphenyl)-1;3-thiazolium-5-thyolate (CMMTT), a newly synthesized mesoionic compound, in rat superior mesenteric arteries. In phenylephrine (10 μM)–pre-contracted mesenteric rings, CMMTT (10−14 – 10−6 M) induced a concentration-dependent relaxation [pD2 = 10.26 ± 0.05, Emax = 80.8 ± 5.8%], and this effect was almost abolished after either removal of the vascular endothelium [Emax = 17.7 ± 4.2%, P<0.001], removal of the vascular endothelium plus100 μM Nω-nitro-<sc>L</sc>-arginine methyl esther (<sc>L</sc>-NAME) [Emax = 21.0 ± 2.0 %, P<0.001], or after pre-treatment of the rings with 100 μM <sc>L</sc>-NAME [Emax = 13.3 ± 2.4%, P<0.001] or 10 μM 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ) [Emax = 13.6 ± 4.8%, P<0.001]. However, endothelium-dependent relaxation induced by CMMTT was not significantly modified after 1 μM indomethacin plus 1 nM atropine [pD2 = 11.12 ± 0.08, Emax = 73.8 ± 5.15%] or 100 nM charybdotoxin (ChTX) plus 100 nM apamin [pD2 = 10.89 ± 0.08, Emax = 58.91 ± 9.8%]. In mesenteric rings, CMMTT (10−6 M) was able to increase nitric oxide (NO)x levels, and this effect was abolished after removal of the vascular endothelium. In conclusion, the present study, using combined functional and biochemical approaches, demonstrated that CMMTT induced a significant vasorelaxant effect, almost completely mediated by the endothelium, likely via NO release and activation of the NO–cGMP pathway.
- 社団法人 日本薬理学会の論文
- 2009-05-20
著者
-
Medeiros Isac
Laboratorio De Tecnologia Farmaceutica Universidade Federal Da Paraiba
-
De Azevedo
Department Of Dermatology University Of Sao Paulo Medical School
-
Cavalcante Karla
Laboratorio De Tecnologia Farmaceutica Universidade Federal Da Paraiba
-
CORREIA Nadja
Departamento de Fisiologia e Patologia, Universidade Federal da Paraiba
-
DIAS Katy
Laboratorio de Tecnologia Farmaceutica, Universidade Federal da Paraiba
-
SILVA Darizy
Laboratorio de Tecnologia Farmaceutica, Universidade Federal da Paraiba
-
SILVA-FILHO Jose
Laboratorio de Tecnologia Farmaceutica, Universidade Federal da Paraiba
-
ARAUJO Islania
Laboratorio de Tecnologia Farmaceutica, Universidade Federal da Paraiba
-
LIRA Bruno
Laboratorio de Tecnologia Farmaceutica, Universidade Federal da Paraiba
-
ATHAYDE-FILHO Petronio
Laboratorio de Tecnologia Farmaceutica, Universidade Federal da Paraiba
-
Correia Nadja
Departamento De Fisiologia E Patologia Universidade Federal Da Paraiba
-
Araujo Islania
Laboratorio De Tecnologia Farmaceutica Universidade Federal Da Paraiba
-
Dias Katy
Laboratorio De Tecnologia Farmaceutica Universidade Federal Da Paraiba
-
Silva-filho Jose
Laboratorio De Tecnologia Farmaceutica Universidade Federal Da Paraiba
-
Lira Bruno
Laboratorio De Tecnologia Farmaceutica Universidade Federal Da Paraiba
-
Silva Darizy
Laboratorio De Tecnologia Farmaceutica Universidade Federal Da Paraiba
-
Athayde-filho Petronio
Laboratorio De Tecnologia Farmaceutica Universidade Federal Da Paraiba
-
Medeiros Isac
Laboratório de Tecnologia Farmacêutica (LTF), Universidade Federal da Paraíba (UFPB)
関連論文
- Disseminated Cytomegalovirus Disease as a Cause of Prolonged Fever in a Bullous Pemphigoid Patient under Systemic Steroid Therapy
- Endothelium-Derived Nitric Oxide Contributes to the Vasorelaxant Response Induced by Mesoionic 2-(4-Chlorophenyl)-3-methyl-4-(4-methoxyphenyl)-3;3-thiazolium-5-thyolate (CMMTT) in Rats
- Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST